9 June 202116 June 2021 Ginkgo Bioworks going public for $15bn SPAC deal Company will be a publicly-traded company on the New York Stock Exchange and will continue to make other filings with the SEC in line with public company requirements
27 September 201924 September 2019 Synthetic Biology Unicorn Ginkgo Bioworks Raises An Additional $290 Million Company's dev shop for genetic programming is now worth $4 billion
3 May 20199 September 2021 International Effort Launches to Determine Best Bet CO2 Utilization Technologies Economic and Environmental Guidelines Will Support New Industries and Climate Solutions
